MASTER SERVICES AGREEMENTMaster Services Agreement • March 17th, 2020 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
Contract Type FiledMarch 17th, 2020 Company Industry JurisdictionThis Master Services Agreement (this “Agreement”) is made effective as of March 3, 2020 (“Effective Date”), by and between Generex Biotechnology Corporation, a Delaware corporation (“Generex”), with offices at 10102 USA Today Way, Miramar, FL 33025, and EpiVax Inc., a Rhode Island corporation (“EpiVax”), with offices at 188 Valley Street, Suite 424, Providence, RI 02909.